Evidence map›Paper›PMID 40841663›Full record

ArticleVirology journal2025

Molecular investigation on measles cases rise and variants co-circulation in the Lazio region, Italy.

Cesare Ernesto Maria Gruber, Silvia Gioacchini, Lavinia Fabeni, Martina Rueca, Licia Bordi, Eleonora Lalle, Melissa Baggieri, Paola Bucci, Raoul Fioravanti, Roberto Giuseppetti and 14 more

Abstract read
In one paragraph

Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Cesare Ernesto Maria GruberBioinformatics Research Unit in Infectious Diseases, National Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-8831-3380
Silvia GioacchiniDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-0912-1330
Lavinia FabeniNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0002-2975-8611
Martina RuecaNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0001-5162-046X
Licia BordiNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0003-3962-3646
Eleonora LalleNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0002-7063-9905
Melissa BaggieriDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-0226-7599
Paola BucciDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0003-0615-1013
Raoul FioravantiDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-0151-0331
Roberto GiuseppettiDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0001-9958-164X
Eliana SpecchiarelloNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0001-5277-3417
Pietro Giorgio SpeziaNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0002-6743-014X
Giulia BernoNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0003-0331-2627
Fabrizio CarlettiNational Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0003-1952-5117
Gabriella De CarliNational Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Regional Service for Surveillance and Control of Infectious Diseases, Rome, Italy. gabriella.decarli@inmi.it.ORCID http://orcid.org/0000-0002-3972-8301
Maria Concetta FuscoNational Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Regional Service for Surveillance and Control of Infectious Diseases, Rome, Italy.
Alessandra BarcaLazio Region, Directorate for Health and Social Policy, Rome, Italy.
Paola ScognamiglioNational Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Regional Service for Surveillance and Control of Infectious Diseases, Rome, Italy.ORCID http://orcid.org/0000-0002-7938-6457
Antonella MarchiDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0003-4713-9758
Emilio D'UgoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0001-5852-7575
Enrico GirardiNational Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Scientific Direction, Rome, Italy.ORCID http://orcid.org/0000-0001-8182-5896
Francesco VairoNational Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Regional Service for Surveillance and Control of Infectious Diseases, Rome, Italy.ORCID http://orcid.org/0000-0002-8375-7468
Fabio Magurano *Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-0394-7043
Fabrizio Maggi *National Institute for Infectious Diseases "Lazzaro Spallanzani" -IRCCS, Laboratory of Virology, Rome, Italy.ORCID http://orcid.org/0000-0001-7489-5271

Funding

Ministero della Salute 5 per Mille Project 5M-2020-23682104
6 · The paper itself

Abstract

purposeIn 2023-2024, measles cases progressively increased in Europe. Multiple outbreaks were reported and viral strains with three-nucleotide mutations potentially compromising diagnostic testing were identified. We analyzed the first cases of measles reported in Lazio (Central Italy) from September 2023 to March 2024, combining molecular characterization and phylogenetic analysis with epidemiological investigation to identify transmission chains and evaluate the sensitivity of PCR tests adopted on circulating viral strains.

methodsWe tested samples collected through routine measles and rubella surveillance for IgM, IgG and Real-Time PCR. We sequenced positive samples with higher viral titers using an amplicon-based whole-genome next-generation sequencing (WG-NGS) approach and performed mutational and phylogenetic analysis. Furthermore, we tested the sensitivity of the PCR molecular diagnostic assay adopted in our laboratory to identify the mutated strains.

resultsOf the 39 suspected cases, 28 were confirmed. Endemic cases were 82%; of these, 78% were sporadic at epidemiological investigation. From 21 high-titer samples, we obtained 14 strains belonging to the D8 genotype. Phylogenetic analysis identified four distinct clusters: three associating 50% of sporadic cases, and one confirming the epidemiological investigation. Several mutational patterns were identified, one of which had three nucleotide mutations potentially affecting the diagnostic test. However, our routine diagnostic PCR tests are able to detect mutated strains at different dilutions.

conclusionOur results demonstrate that WG-NGS can be used to distinguish transmission chains and identify infection clusters to improve surveillance activity and enable the implementation of more targeted control measures, highlighting the importance of integrated epidemiological and genomic surveillance.

Indexed as

MeaslesMeasles virusAdolescentAntibodies, ViralChildChild, PreschoolDisease OutbreaksFemaleGenotypeHigh-Throughput Nucleotide SequencingHumansInfantItalyMaleMutationPhylogenyAntibodies, ViralDiagnosticsMeaslesMolecular epidemiologyPolymerase-chain reactionVirus variantsWhole-genome sequencing

Identifiers

PMID40841663
PMCPMC12369050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.